about
Receptor-like function of heparin in the binding and uptake of neutral lipids.alpha-L-iduronate ring conformations in heparin and heparin derivatives. 13-C Nuclear-magnetic-resonance analysis and titration data for variously desulphated and periodate-oxidized heparins.Mutation of conserved cysteines in the Ly6 domain of GPIHBP1 in familial chylomicronemia.GPIHBP1, an endothelial cell transporter for lipoprotein lipase.Regulation of lipoprotein lipase in primary cultures of isolated human adipocytesBinding of diamine oxidase activity to rat and guinea pig microvascular endothelial cells. Comparisons with lipoprotein lipase bindingLipoprotein lipase, hepatic lipase, and carnitine in premature infants.Effects of heparin on platelet aggregation and release and thromboxane A2 production.Proteoglycans in the microvasculature. I. Histochemical localization in microvessels of the rabbit eye.Synergistic effect of heparin and chemotactic factor on polymorphonuclear leukocyte aggregation and degranulation.Involvement of cell surface heparin sulfate in the binding of lipoprotein lipase to cultured bovine endothelial cells.Effect of heparin and heparin fractions on platelet aggregationMechanism of inhibition of mammalian DNA topoisomerase I by heparin.The GPIHBP1-LPL complex is responsible for the margination of triglyceride-rich lipoproteins in capillaries.Glycogen, hyaluronate, and some other polysaccharides greatly enhance the formation of exolipase by Serratia marcescens.ORG 10172: a low molecular weight heparinoid anticoagulant with a long half-life in man.Identification of the core proteins in proteoglycans synthesized by vascular endothelial cellsBinding of active and inactive forms of lipoprotein lipase to heparin. Effects of pH.Lipoprotein lipase activity of rat cardiac muscle. Changes in the enzyme activity during incubations of isolated cardiac-muscle cells in vitro.Differences in the metabolism of very-low-density lipoproteins by isolated beating-heart cells and the isolated perfused rat heart. Evidence for collagenase-released extracellular lipoprotein lipase.Binding of the asymmetric forms of acetylcholinesterase to heparinRapid effects of isoprenaline, glucagon, pacing and potassium arrest on post-heparin lipoprotein lipase activity in the perfused rat heart.Structural studies on heparan sulphate from human lung fibroblasts. Characterization of oligosaccharides obtained by selective periodate oxidation of D-glucuronic acid residues followed by scission in alkali.Interaction of lipoprotein lipase with native and modified heparin-like polysaccharidesStructure of heparin-derived tetrasaccharides.The lipoprotein lipase of white adipose tissue. Changes in the adipocyte cell-surface content of enzyme in response to extracellular effectors in vitro.Neural 16S acetylcholinesterase is solubilized by heparin.Effects of insulin, glucocorticoids and adrenaline on the activity of rat adipose-tissue lipoprotein lipids.Interaction of lipoprotein lipase with heparin-Sepharose. Evaluation of conditions for affinity binding.
P2860
Q33653617-D2AA1A27-3C24-4684-BD27-BCE83AC3AB0AQ33920027-EDE66ABE-7AB0-4471-AF6A-D49701678AD1Q34089350-E53038A6-F0E5-48B7-9588-9FF53E3C7C5FQ34208235-793BD65C-D4F8-4259-BF68-B1A3BA38461FQ34523925-78543D14-2BC7-4853-A058-CA20CDBEE3E0Q34541160-A8C74F2D-9CF8-4F2F-BA8A-FCA491E57691Q35604342-159C032F-FF03-4245-8694-C7FA93BD238EQ35863908-63E1B477-CAC8-470B-A68A-5E68D032A0D2Q35864166-8D984AC0-732E-4A85-B12C-64964D874663Q35885740-94E8AB2C-7668-4972-B353-0C9383EBF735Q37004264-CA275EE8-6911-44FC-9DD7-ADCCFEF79D69Q37019110-41C15A75-3902-4BAF-934E-504A0B738080Q38349989-AF286ED0-10AC-492D-80F1-4A2BC76B5140Q39004975-3C7D4B29-F448-496C-8A96-651D296E47F1Q39977682-1A13AE7E-2D8A-4003-A787-DE958780497AQ41768587-5AA4266D-8DCD-405C-9D80-3D6582303B5FQ41782674-EA0FAA94-88BA-4643-8238-727A37C1471CQ41789228-3703581C-8D43-4A0E-B141-BDD24841341AQ41855770-819F4E61-9C3A-455F-8031-27AD3D7C3DC1Q41968045-251EBE8C-BBD3-4A69-8822-D9C88F15DF65Q41971694-B277E4CB-E059-4662-BD9B-1F7E441245DEQ41982355-4F7FC9B2-5342-48DD-B62B-EF9384950E4BQ42046403-6AAEA13B-A2DB-4769-BB4E-B7428047368CQ42177560-18B9EAE9-F547-4038-B0FC-BB546E3A9349Q42670467-E6D6D0C1-CB3C-4E6D-B4BB-50BE7FE7F076Q42854384-7B339C7F-E30B-44F1-8281-5CF7739E3486Q42865508-B9AC0237-1721-4A05-8854-C96E37D3F3C9Q42882544-CC98B6FA-973E-4CBC-A71D-4B5A63155D1DQ42908810-7194B1E9-75FA-41F3-B8ED-E97339576468
P2860
description
1977 nî lūn-bûn
@nan
1977年の論文
@ja
1977年学术文章
@wuu
1977年学术文章
@zh-cn
1977年学术文章
@zh-hans
1977年学术文章
@zh-my
1977年学术文章
@zh-sg
1977年學術文章
@yue
1977年學術文章
@zh
1977年學術文章
@zh-hant
name
Heparin-lipoprotein lipase interactions.
@en
Heparin-lipoprotein lipase interactions.
@nl
type
label
Heparin-lipoprotein lipase interactions.
@en
Heparin-lipoprotein lipase interactions.
@nl
prefLabel
Heparin-lipoprotein lipase interactions.
@en
Heparin-lipoprotein lipase interactions.
@nl
P2093
P1433
P1476
Heparin-lipoprotein lipase interactions.
@en
P2093
Bengtsson G
Marklund SE
Olivecrona T
P407
P50
P577
1977-01-01T00:00:00Z